title: First cystic fibrosis drug advances towards approval.
authors.forename: Cormac
authors.initials: C
authors.lastname: Sheridan
mesh_terms: D000627:Aminophenols / Q000494:pharmacology* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003001:Cloning, Molecular; D003550:Cystic Fibrosis / Q000188:drug therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods; D015363:Quinolones / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000627:Aminophenols; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; C505032:CFTR protein, human; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor